Iatrogenic acquired factor V inhibitors: A case report and review of the French pharmacovigilance database-Reference-Cited by-同舟云学术

Iatrogenic acquired factor V inhibitors: A case report and review of the French pharmacovigilance database

Published:2017-09 Issue: Volume:157 Page:154-156
ISSN:0049-3848
Container-title:Thrombosis Research
language:en
Short-container-title:Thrombosis Research

Author:

Theron Alexandre,Burcheri Sara,Vacheret Fabienne,Hillaire-Buys Dominique,Sauguet Pauline,Schved Jean-François,Faillie Jean-Luc,Biron-Andreani Christine

Publisher

Elsevier BV

Subject

Hematology

Reference13 articles.

1. Acquired inhibitors of clotting factors: AICE recommendations for diagnosis and management;Franchini;Blood Transfus.,2015

2. Acquired factor V inhibitors;Knöbl;Baillieres Clin. Haematol.,1998

3. Acquired factor V inhibitors: a systematic review;Franchini;J. Thromb. Thrombolysis,2011

4. Clinical and laboratory manifestations of anti-factor V antibodies;Ortel;J. Lab. Clin. Med.,1999

5. Spectrum of bleeding in acquired factor V inhibitor: a summary of 33 cases;Wiwantikit;Clin. Appl. Thromb. Haemost.,2006

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rare acquired factor V inhibitors combined with positive lupus anticoagulant that successfully treated by plasmapheresis and prednisone acetate: a typical case report;Annals of Hematology;2023-05-06

2. Acquired factor V inhibitor: a nation‐wide study of 38 patients;British Journal of Haematology;2021-01-20

3. Acquired factor V inhibitors after allogeneic hematopoietic stem cell transplantation in a dog;Journal of Veterinary Internal Medicine;2020-07-20

4. Ceftriaxone/Metronidazole/Ofloxacin;Reactions Weekly;2017-09